After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...
To schedule time for flow analysis, call 977-8877. Leave a message if you are unable to reach us immediately and we will return your call as soon as possible. Users are also welcome to stop by the ...
Flow-based methods allow researchers to collect multiparameter data from individual cells in their samples, but the fate of samples depends on the instrument. In addition to cell analysis, cell ...
Flow cytometry offers practical advantages for real-time monitoring of CAR T cell expansion, persistence, and toxicity risk in aggressive large B-cell lymphoma patients. Early CAR T cell expansion is ...
Flow cytometry is an invaluable method for biomedical research. Since its development over 50 years ago, technology for flow cytometry has progressed rapidly, allowing for the detection of more and ...
Over the past five years, the FCSC has invested $3.5 million in replacing or updating its instruments, expanding capacity, and developing new services such as multiplex immunofluorescence, Hanumanthu ...
Flow cytometry is widely used in areas of research that require analysis or isolation of cells from suspension. This technology makes use of fluorescent probes targeted to specific cell-associated ...
Scientists prepare samples as single cell suspensions and labels components of interest with fluorescent antibodies or other probes. The cytometer uses pumps to draw the sample through tubing to ...
Cytek Biosciences, Inc. has announced the launch of the Cytek Aurora™ Evo system, an advanced full spectrum flow cytometer designed to enhance cell analysis capabilities. Building on the success of ...
SAN DIEGO--(BUSINESS WIRE)--Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results